Valuation: Formycon AG

Market Cap 349M 400M 328M 300M 562M 38.2B 562M 3.94B 1.52B 19.51B 1.5B 1.47B 62.89B P/E 2026 *
659x
P/E 2027 * 14.9x
Enterprise Value 463M 530M 436M 397M 746M 50.69B 746M 5.23B 2.02B 25.89B 1.99B 1.95B 83.46B EV / Sales 2026 *
6.38x
EV / Sales 2027 * 4.12x
Free-Float
70%
Yield 2026 *
-
Yield 2027 * -
1 day-1.92%
1 week-2.42%
Current month+0.62%
1 month+0.10%
3 months-4.86%
6 months+12.04%
Current year-24.38%
1 week 19.24
Extreme 19.24
20
1 month 18.38
Extreme 18.38
20.9
Current year 15.8
Extreme 15.8
26.95
1 year 15.8
Extreme 15.8
26.95
3 years 15.8
Extreme 15.8
67.8
5 years 15.8
Extreme 15.8
94.1
10 years 14.65
Extreme 14.65
94.1
Manager TitleAgeSince
Chief Executive Officer - 01/07/2022
Director of Finance/CFO 57 01/04/2023
Chief Tech/Sci/R&D Officer - 01/07/2022
Director TitleAgeSince
Director/Board Member 49 10/12/2020
Chairman 54 12/06/2024
Director/Board Member 54 12/06/2024
Date Insider Type Main position Quantity % Market Cap. Importance
21/02/25 Buy

Chief Technology Officer

160 0.0009%
29/04/24 Buy

Executive/Senior Manager

1,200 0.0068%
24/04/24 Buy

Chief Executive Officer

2,500 0.0142%
Change 5-day change 1-year change 3-year change Capi.($)
-1.92%-2.42%-17.26%-64.74% 400M
-0.12%+4.38%+4.27%+30.06% 47.86B
+0.08%+0.16%+43.79%+35.89% 44.46B
+0.66%+6.23%+8.96%+93.14% 41.85B
+0.05%-5.86%+334.27%+542.87% 41.34B
-1.60%+0.56%+10.84%+46.93% 30.04B
+0.96%+1.56%+26.52%+159.67% 17.59B
-0.01%-0.92% - - 15.6B
-0.91%+4.74%+25.30%+42.93% 15.69B
-1.08%+12.11%-10.11% - 13.93B
Average -0.29%+2.31%+47.40%+110.84% 26.88B
Weighted average by Cap. -0.07%+2.13%+68.68%+143.13%

Financials

2026 *2027 *
Net sales 72.66M 83.14M 68.29M 62.32M 117M 7.95B 117M 820M 316M 4.06B 312M 305M 13.08B 112M 129M 106M 96.39M 181M 12.29B 181M 1.27B 489M 6.28B 483M 472M 20.24B
Net income 343K 392K 322K 294K 552K 37.52M 552K 3.87M 1.49M 19.16M 1.47M 1.44M 61.77M 23.19M 26.54M 21.8M 19.89M 37.33M 2.54B 37.34M 262M 101M 1.3B 99.66M 97.47M 4.18B
Net Debt 114M 131M 107M 97.94M 184M 12.49B 184M 1.29B 497M 6.38B 491M 480M 20.57B 113M 130M 107M 97.26M 183M 12.4B 183M 1.28B 494M 6.33B 487M 477M 20.42B
Logo Formycon AG
Formycon AG is a Germany based Company. The Company is engaged in providing biosimilar drugs and formulations. The Company focuses on treatments in ophthalmology, immunology and other chronic diseases, covering all steps of biosimilar development process, from early-stage analysis of the originator drug to the preclinical and clinical testing phases, as well as the preparation of dossiers for marketing approval.
Employees
196
Date Price Change Volume
23/09/26 19.36 -2.02% 18
22/09/26 €19.76 +2.70% 1,232
21/09/26 €19.24 -1.84% 3,195
18/09/26 €19.60 -1.01% 420
17/09/26 €19.80 -0.20% 1,873
Trader
Investor
-
Global
-
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
19.76EUR
Average target price
39.67EUR
Spread / Average Target
+100.74%

Quarterly revenue - Rate of surprise

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!